Hamps Bio share price hits 5% upper circuit despite stock market crash, trades 60.5% above IPO price
6 days ago

Hamps Bio share price hits 5% upper circuit despite stock market crash, trades 60.5% above IPO price

Live Mint  

Hamps Bio share price: Continuing their winning run for the second trading session on Friday, January 3, shares of Hamps Bio, the recent debutant on Dalal Street, were locked in the 5% upper circuit limit at ₹81.86 apiece. The company’s shares made a stellar stock market debut on December 20, listing at ₹96.9, a 90% premium over the issue price of ₹51. About Hamps Bio The company is engaged in the marketing and distribution of pharmaceutical formulation products across a wide range of dosages, including tablets, syrups, capsules, injectables, oil, gel, and powder, used as medicines and nutritional supplements. Hamps Bio sells its products through a network of more than 50 distributors as of March 31, 2024, and e-commerce platforms, including Amazon.com, Amazon.ca, Amazon.eu, Flipkart, and JioMart.

History of this topic

Hamps Bio share price hits 5% lower circuit, slips below listing price
1 week, 6 days ago
Hamps Bio share price sees a blockbuster debut; stock opens with 90% premium at ₹96.90 apiece on BSE SME
2 weeks, 6 days ago
Hamps Bio IPO Day 2: Latest GMP, subscription status, listing date, other details about SME IPO
3 weeks, 5 days ago
Muted IPO Debut for Godavari Biorefineries: GMP Indicates Caution for Investors
2 months, 1 week ago
Manglam Infra and Engineering share price hits 5% upper circuit after stellar listing
5 months, 1 week ago

Discover Related